Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04759846
Title Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Pierre Fabre Medicament
Indications

skin melanoma

melanoma

Therapies

Binimetinib + Encorafenib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST